Skip to main content
Figure 2 | Experimental Hematology & Oncology

Figure 2

From: Modelling of a genetically diverse evolution of Systemic Mastocytosis with Chronic Myelomonocytic Leukemia (SM-CMML) by Next Generation Sequencing

Figure 2

Verification of identified variants by Sanger sequencing. A: Representative sequences of CBFA2T3, CLTCL1, and BLM using DNA derived from the SM part of BMT, PB, and the SM part of BMT, respectively. B: Sequencing of TET2 and RUNX1 using DNA derived from PB, the SM part of BMT, and normal tissue. C: Sequencing of TET2 and RUNX1 using DNA derived from FACS sorted PB cell populations.

Back to article page